TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today the appointment of Peter Powchik, M.D., as Senior Vice President of Clinical Development to lead the Company’s clinical development efforts. Dr. Powchik will report to George Yancopoulos, M.D., Ph.D, President, Regeneron Research Laboratories.
